Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats

Kidney International, Vol. 54 (1998), pp. 1150 –1156

Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats WEI-ZHONG YING and PAUL W. SANDERS Nephrology Research and Training Center, Comprehensive Cancer Center, and Cell Adhesion and Matrix Research Center, Division of Nephrology, Department of Medicine and Department of Physiology & Biophysics, University of Alabama at Birmingham, and Department of Veterans Affairs Medical Center, Birmingham, Alabama, USA

Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats. Background. Tamm-Horsfall glycoprotein (THP) is a unique protein that is produced exclusively by cells of the thick ascending limb of Henle’s loop (TALH). This study examined whether dietary salt altered renal THP production. Methods. Male Sprague-Dawley rats were examined on days 1, 4, and 15 following placement in metabolic cages on diet that contained 0.3%, 1.0% or 8.0% NaCl. THP expression was quantified using Northern hybridization and Western blotting analysis. Results. An increase in dietary salt produced sustained increases in relative steady-state mRNA and protein levels of THP in the kidney. Addition of furosemide, but not chlorothiazide, to animals on the 8.0% NaCl diet further augmented steady-state mRNA levels of THP. Conclusions. An increase in dietary salt and the loop diuretic, furosemide, increased expression of THP in the rat. The data support the involvement of this unique protein in the function of the TALH during changes in dietary salt. These findings also suggest that restriction of dietary salt may be beneficial in cast nephropathy in multiple myeloma and recurrent nephrolithiasis, two diseases in which THP can play an important pathogenetic role.

Tamm-Horsfall glycoprotein (THP) was described initially as a urinary protein that inhibited viral hemagglutination [1]. Subsequently, Muchmore and Decker identified a urinary protein that possessed immunosuppressive properties in vitro and hence coined the term uromodulin [2]. Interest in uromodulin resulted in cloning of this protein, which was identified as THP [3, 4]; however, when further studies did not suggest a major physiological function in immune modulation, enthusiasm for the study of THP diminished. The function of THP remained undefined, but

Key words: uromodulin, thick ascending limb of the loop of Henle, furosemide, chlorothiazide, gene expression. Received for publication March 4, 1998 and in revised form May 11, 1998 Accepted for publication May 11, 1998

© 1998 by the International Society of Nephrology

the exclusive production by cells of the thick ascending limb of the loop of Henle (TALH) along with a striking absence of THP mRNA in the macula densa [5], a specialized portion of the TALH involved in the detection of the luminal concentration of sodium chloride, suggested an involvement in salt and water transport in the TALH. However, the absence of aquaporins in the TALH [6 – 8] has been proposed as the mechanism of water impermeability of that segment. Along with studies showing that water intake did not alter THP production [9], involvement of THP in water transport in the TALH appeared unlikely. Although not proven, THP may modulate salt transport in the TALH. We hypothesized that changes in dietary salt and the addition of a loop diuretic altered the production of THP. Understanding the involvement of these parameters in THP expression is also potentially useful in the therapy of diseases where THP plays an important role, such as cast nephropathy (“myeloma kidney”) [10 –15] and nephrolithiasis [16]. Using Northern hybridization and Western blotting, the current study determined whether dietary salt affected relative steady-state mRNA and renal protein content of THP in Sprague-Dawley rats. METHODS Animal preparation Seventy-six male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA, USA), 28 days of age, were housed under standard conditions and given 0.3% (lowsalt) diet (AIN-76A with 0.3% NaCl; Dyets, Inc., Bethlehem, PA, USA) and water ad libitum for four days before initiating the experiment. Animals were used at this age because previous experiments showed preservation of blood pressure and inulin clearance for two weeks on an 8.0% NaCl diet [17]. Maintaining the animals on a 0.3% NaCl diet allowed the establishment of a baseline standardized diet before initiation of study. Rats were then placed in metabolic cages and allowed free access to a water and rat diet, which contained 0.3% (termed the Lo-salt group),

1150

1151

Ying and Sanders: Dietary salt controls production of THP Table 1. Compiled data of the groups of animals in the study

Group

Day of study

Number of animals

Body wt g

Serum [Na1] mEq/liter

Lo-salt Nor-salt Hi-salt Lo-salt Nor-salt Hi-salt Hi-F Hi-C Lo-salt Nor-salt Hi-salt

1 1 1 4 4 4 4 4 15 15 15

8 4 8 12 4 12 4 4 7 4 8

110 6 6 128 6 4 115 6 4 121 6 10 142 6 5 135 6 7 133 6 3 140 6 2 190 6 13 223 6 11 178 6 7

143 6 4 ND 145 6 6 146 6 3 ND 148 6 4 152 6 4 154 6 5 137 6 4 ND 136 6 5

˙ ml/day UV

˙ UNa1V mEq/min

˙ UK1V mEq/min

per 100 g body weight 7.4 6 0.6 9.1 6 0.5 38.0 6 2.2a 8.9 6 1.1b 11.2 6 0.7b 57.7 6 5.6 67.2 6 4.5 71.1 6 3.2 15.6 6 3.0b 28.0 6 3.6b 87.0 6 9.3

0.13 6 0.02 2.3 6 0.2 12.2 6 1.0a 0.2 6 0.03b 3.1 6 0.5b 19.8 6 2.2 20.0 6 0.7 22.8 6 0.7 0.6 6 0.2b 8.3 6 1.2b 48.3 6 10.6

0.2 6 0.04a 0.8 6 0.1 0.8 6 0.1 0.3 6 0.1a 1.1 6 0.2 1.2 6 0.2 0.8 6 0.1 1.1 6 0.1 1.0 6 0.2a 2.6 6 0.4 2.2 6 0.3

ND is not done P , 0.05, compared to the other groups examined on that day b P , 0.05, compared to the group on the 8.0% NaCl chow (Hi-salt) for the same duration a

1.0% (AIN-76A with 0.3% NaCl; Dyets, Inc.; the Mid-salt group) or 8.0% (AIN-76A containing 8.0% NaCl, Dyets, Inc.; the Hi-salt group) sodium chloride. Urine was collected under oil to prevent desiccation. Food consumption, urine flow and body weights were recorded daily. In other experiments, rats on the high-salt diet received intraperitoneal injections of either furosemide (Elkins-Sinn, Inc., Cherry Hill, NJ, USA), 5 mg/kg, (denoted Hi-F), or chlorothiazide (Merck & Co., West Point, PA, USA), 4 mg/kg (Hi-C), twice daily. Animals on the low-salt and high-salt diets were killed on days 1, 4 and 15. Because of the potential variable food and water intake, experiments were not concluded before 24 hours. Both kidneys were immediately harvested under aseptic conditions and either snapfrozen in liquid nitrogen to isolate total RNA (see below) or placed in a chilled solution that contained 250 mM sucrose, 10 mM triethanolamine, 5 mg/ml leupeptin, 5 mg/ml aprotinin and 0.1 mg/ml phenylmethylsulfonyl fluoride (pH 7.6; all from Sigma Chemical Co., St. Louis, MO, USA) in order to obtain protein for Western blotting (see below). Blood was collected for determination of serum sodium concentration. Plasma and urine samples were analyzed for sodium and potassium using flame photometry (model IL-943; Instrumentation Laboratories, Inc., Lexington, MA, USA). Rat THP purification and description of monoclonal anti-THP antibody Rat THP was prepared by precipitation from urine using 0.64 M NaCl, according to the original protocol of Tamm and Horsfall [1]. Purity of the isolated THP was established by Coomassie blue staining following electrophoresis (SDSPAGE) using a 10% polyacrylamide gel. A mouse monoclonal anti-human THP antibody (#5B4E2) was raised in our laboratory and purified from the medium using ammonium sulfate precipitation, as described previously [10]. This monoclonal antibody reacted with deglycosylated hu-

man THP and thus was directed against a peptide portion of the molecule. Immunoblotting was performed to determine whether this monoclonal antibody also recognized rat THP. Following SDS-PAGE using 10% polyacrylamide gel under reducing conditions, rat THP was transferred onto a nitrocellulose membrane. After washing and blocking unbound sites on the nitrocellulose membrane in standard fashion, the membrane was incubated with our mouse anti-human THP monoclonal antibody, 50 mg/ml in phosphate-buffered saline containing 5% nonfat milk (Sigma Chemical Co.), followed by goat anti-mouse IgG conjugated with horseradish peroxidase (Bio-Rad, Melville, NY, USA), 1:2000 dilution in phosphate-buffered saline. After additional washes, the membrane was developed using ECL Western blotting system (Amersham International plc., Buckinghamshire, UK) and XAR-5 film (Kodak, Rochester, NY, USA). Under these conditions, a single band at approximately 100 kD was identified, demonstrating immunoreactivity with rat THP (data not shown). Western blot analysis Protein was harvested from kidneys using the protocol of Ecelbarger and associates; this protocol recovered membrane-bound proteins and was used to examine THP expression in that study [18]. Following placement of the kidney in chilled membrane-isolation solution containing 250 mM sucrose, 10 mM triethanolamine, 5 mg/ml leupeptin, 5 mg/ml aprotinin and 0.1 mg/ml phenylmethylsulfonyl fluoride (pH 7.6; all from Sigma Chemical Co.), the medulla was dissected and then homogenized using a tissue homogenizer (Omni-Mixer 17105; Omni Co., Waterbury, CT, USA) in the same isolation solution. The homogenized tissue was initially centrifuged at 1,000 3 g for 10 minutes, and the supernatant was collected. To increase yield and to effect more thorough homogenization, the pellet was again homogenized and centrifuged at 1,000 3 g for 10 minutes.

1152

Ying and Sanders: Dietary salt controls production of THP

Fig. 1. Northern analysis using total RNA from kidneys of rats on an 8.0% or 0.3% NaCl diet. Samples were processed simultaneously and run on the same gel. Animals were examined after one day (N 5 4 animals in each group) and after 15 days (N 5 4 in Hi-salt group and N 5 3 in Lo-salt group) in metabolic cages while on these two diets. Steady-state levels of mRNA of THP were greater in the Hi-salt group compared to the corresponding Lo-salt group examined at the same time point, by the first day of study, and remained elevated through day 15. The locations of 18S and 28S ribosomal RNA in the gel were represented by the arrows.

SDS-polyacrylamide minigels (Mini-PROTEAN II; BioRad Laboratory), and size-fractionated. The proteins were electrophoretically transferred onto nitrocellulose membrane. After blocking in 5% nonfat milk (Sigma Chemical Co.), the membrane was probed with the mouse monoclonal anti-THP antibody, 50 mg/ml in phosphate-buffered saline containing 5% milk. Following addition of goat anti-mouse IgG conjugated with horseradish peroxidase (Bio-Rad Laboratory), 1:3000 dilution in phosphate-buffered saline, the membrane was developed using peroxidase substrate (0.8 mg/ml 3,39-diaminobenzidine in phosphatebuffered saline; 0.01% hydrogen peroxide; all from Sigma Chemical Co.). To quantify the amount of THP in each sample, the density of each band was determined using a densitometer (Model 620 Video Densitometer; Bio-Rad Laboratory). Northern hybridization analysis Fig. 2. Summary of mean relative steady-states levels of mRNA of THP of the Hi-salt (f), Lo-salt (M), Hi-F (u), and Hi-C (;) groups in this study. Rats ingesting the 8.0% NaCl diet had sustained increases in steady-state mRNA, compared to rats on 0.3% NaCl diet for the same duration. Addition of furosemide, but not chlorothiazide, further increased steadystate mRNA, compared to the other groups of animals in the study for four days. *P , 0.05 than the corresponding Hi-salt group on that day of study; ‡P , 0.05 than the other three groups on that day of study.

This supernatant was combined with the previous collection. Crude membrane samples were prepared using a single-speed fractionation procedure, which was characterized previously [7, 18]. In this protocol, the supernatant was spun at 17,000 3 g for 20 minutes to obtain a pellet. The pellets, which represented the crude plasma membrane preparation, were resuspended in isolation solution and protein concentration was determined using a kit (Micro BCA Protein Assay Reagent Kit; Pierce, Rockford, IL, USA). Samples containing 5 mg of total protein were solubilized at 60°C for 15 minutes in Laemmli sample buffer that contained b-mercaptoethanol, loaded into 8%

Total RNA was isolated by single-step method of acid guanidinium thiocyanate-phenol chloroform extraction [19]. Briefly, kidneys were homogenized in a denaturing solution of 4 M guanidinium isothiocyanate, 0.5% sarcosyl, 0.1 M b-mercaptoethanol in 25 mM sodium citrate (pH 7.0). After phenol/chloroform extraction, the RNA was precipitated twice with isopropanol and washed with 70% ethanol. The concentration and purity of RNA in each sample was determined using optical density at 260 and 280 nm. Fifteen micrograms of total RNA from each sample was electrophoresed in 1.0% agarose gels containing 2.2 M formaldehyde and 0.2 M MOPS, pH 7.0. Before transfer, each gel was stained with acridine orange to ensure the quality of the RNA and to determine the location of the 18S and 28S ribosomal RNA. After the gel was rinsed in distilled water, the gel was soaked in 50 mM NaOH for 10 minutes, then the samples were transferred to a nylon membrane (Boehringer Mannheim Products, Mannheim, Germany) using vacuum blotting (Model 785; Bio-Rad Laboratory) in 103 SSC. Nucleic acids were cross-linked by

Ying and Sanders: Dietary salt controls production of THP

1153

Fig. 3. Western blot of membrane preparations obtained from the medulla of rats on the three diets. All samples from the same day were processed simultaneously and run on the same gel. Animals were examined on days 1, 4 and 15. A single band at approximately 100 kD was identified by the mouse monoclonal anti-THP antibody (#5B4E2).

short ultraviolet irradiation (Stratagene, La Jolla, CA, USA). Membranes were prehybridized for 15 minutes at 68°C in a standard hybridization solution (QuikHyb; Stratagene). The membranes were hybridized at 68°C for 60 minutes with a 2.2 kb cDNA probe labeled with a-32PdCTP by random oligonucleotide priming (Prime-a-Gene Labeling system; Promega, Inc., WI, USA). Rat THP cDNA was kindly provided by Dr. George A. Scheele [20]. The blots were washed twice in 23 SSC in 0.1% SDS for 15 minutes at room temperature, followed by a single highstringency wash using 0.13 SSC in 0.1% SDS for 20 to 30 minutes at 60°C. Membranes were exposed to XAR-5 film (Kodak), which was developed after overnight exposure at 280°C. The blots were then stripped in solution containing 1 mM Tris-HCI, pH 8.0, 0.1 mM EDTA and 0.13 Denhardt’s solution, at 75°C for two hours. The membranes were then hybridized using a human glyceraldehyde-3phosphate dehydrogenase (GAPDH) probe, which had been labeled with 32P using the same method as that described above. The human GAPDH probe (plasmid pBR322) was obtained through American Type Culture Collection (Rockville, MD, USA). Autoradiography was then performed as described above. Autoradiographs were scanned using a densitometer (Model 620 Video Densitometer; Bio-Rad Laboratory). The density of the GAPDH band in the same lane was used to normalize mRNA loading. For quantification, the density of the THP bands were individually divided by the density of band for GAPDH in the same lane.

Statistical analysis All data were expressed as mean 6 standard error. Significant differences among data sets were determined using either unpaired t-test or one-way analysis of variance using multiple comparisons by Fisher’s protected least significant difference method, where appropriate. A P value of , 5% was considered significant. RESULTS Mean body wts, food intake, serum [Na1], urinary flow ˙ ), and urinary sodium excretion (UNaV ˙ ) and rate (UV ˙ ) rates of the groups of rats in potassium excretion (UKV this study were shown in Table 1. One animal in the Lo-salt group died of unexplained causes. Mean body wts and serum sodium concentrations did not differ among the groups of rats studied on the same days. As expected, compared to the Lo-salt and Mid-salt groups, rats on the ˙ , UNaV ˙ , and 8.0% NaCl diet exhibited higher mean UV ˙ at each time of study (days 1, 4 and 15). UKV Mean relative steady-state mRNA levels of THP increased (P , 0.05) by the first day and remained elevated throughout the study, indicating a direct effect of dietary salt on production of THP (Figs. 1 and 2). The effect of furosemide was also examined. Four days following addition of furosemide to animals on the high-salt diet (Hi-F), the mean amount of mRNA of THP was greater (P , 0.05) than levels seen in animals on either the high-salt diet or

1154

Ying and Sanders: Dietary salt controls production of THP

Using Western blotting with a monoclonal antibody (#5B4E2) that recognized rat THP (Methods section), an increase in THP protein expression in the medulla was seen after one day on 8.0% NaCl diet and persisted throughout the study (Figs. 3 and 4). Differences in protein expression between animals on 0.3% NaCl diet (Lo-salt) and those on 1.0% NaCl diet (Mid-salt) were also evident.

Fig. 4. Quantification of protein expression in the medulla of rats on the various sodium chloride diets. The amount of THP was greatest (*P , 0.05) in preparations obtained from animals on an 8.0% NaCl diet (Hi-salt, N 5 4 rats), compared to rats on a 1.0% NaCl (Mid-salt, N 5 4) and 0.3% NaCl (Lo-salt, N 5 4) at each of the time points studied. In addition, the amount of THP in preparations from the Mid-salt groups was greater (‡P , 0.05) than that obtained from the Lo-salt groups at each time point examined.

the low-salt diet. However, supplementation of rats on the high-salt diet with chlorothiazide (Hi-C) produced no further increases (Fig. 2).

DISCUSSION Production of THP occurs exclusively in the medullary and cortical portions of the thick ascending limb of the loop of Henle (TALH) [5, 21]. THP belongs to a unique class of glycophospholipid-anchored proteins [22]. This post-translational modification directs THP to the apical surface of cells of the TALH, but the protein remains embedded in the outer leaflet of the lipid bilayer and extends into the tubular lumen [22]. The unique physicochemical properties and anatomic distribution suggest a role for THP in salt transport activity in the TALH. Our current study demonstrated that a high-salt diet increased steady-state levels of mRNA, along with protein expression, of THP in the kidney. The increase in mRNA occurred by the first day on the high-salt diet and remained persistently elevated through the 15-day course of the study. Finally, twice daily administration of the loop diuretic, furosemide, but not chlorothiazide, a diuretic that inhibits salt transport in the early distal convoluted tubule, to rats on the high-salt diet produced further increases in steady-state mRNA levels of THP. Thus, although considered a constitutively produced protein, our findings showed that this process was modified under certain physiological conditions. While our present study did not demonstrate the physiologic role of THP, an increase in THP expression in the TALH, as seen in this study, along with the increase in luminal [NaCl] that occurs in rats during high-salt intake [23], directly promote selfaggregation of THP [24 –26]. Formation of a highly negatively charged, hydrophobic, gelatinous barrier may decrease transepithelial electrolyte flux in the TALH. The effect of changes in dietary salt on THP production was not examined previously. Results of our experiments that used furosemide agreed with several investigators [18, 27], but disagreed with others [9]. Using Western blotting, Ecelbarger and associates clearly showed an increase in THP in kidneys of rats exposed to furosemide [18]. Also, Wirdnam and Milne demonstrated that furosemide stimulated release of THP directly from cortical slices [27]. In contrast to these studies and our current findings, however, Bachmann et al showed that THP excretion did not change one to three weeks following institution of furosemide, 12 mg/day, administered by osmotic minipumps [9]. Although our study administered 5 mg/kg per day by intraperitoneal injection, Ecelbarger and associates [18] administered 10 mg/day by osmotic minipumps over five days. Thus, differences in the doses of furosemide used in these studies does not appear to explain the apparent discrepancy, which was

Ying and Sanders: Dietary salt controls production of THP

not determined. Certainly, THP expression in the kidney may not correlate with protein excretion, which is technically difficult to assay in the urine [28]. In our present study, the combined effect of furosemide and a high-salt diet was greater than the effect of dietary salt alone. In summary, the present study demonstrates that an increase in dietary salt facilitated production of THP in rats. The data also show that furosemide augments this effect and provides additional confirmation of previous studies [18, 27] that showed an effect of furosemide on THP. Our findings suggest an involvement of THP in the physiological function of the TALH. In addition, THP plays an important role in pathological conditions that includes cast nephropathy (“myeloma kidney”) and nephrolithiasis. Cast nephropathy develops when nephrotoxic immunoglobulin light chains bind to THP to produce a poorly soluble complex that precipitates in the lumen of the distal nephron and blocks flow of tubule fluid [10 –15]. Intrarenal expression of THP is particularly important in the pathogenesis of this lesion. The role of THP in nephrolithiasis is complex [16, 29, 30]. While THP from healthy volunteers serves as an inhibitor of calcium oxalate formation, THP from patients with recurrent stone formation augments calcium oxalate aggregation [16]. In addition, a diet high in sodium has been suggested to facilitate renal stone formation [31, 32]. By facilitating intrarenal expression of THP, a high-salt diet, with or without furosemide, may produce detrimental effects on renal function in patients with multiple myeloma and facilitate renal stone formation in predisposed individuals. ACKNOWLEDGMENTS This work was supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, and National Institutes of Health grant DK-46199. Portions of this manuscript have been published in abstract form (J Am Soc Nephrol 8:607A, 1997). The authors especially thank Dr. George A. Scheele for his very helpful discussions and providing the cDNA for rat THP. Reprint requests to Paul W. Sanders, M.D., Division of Nephrology/ Department of Medicine, 642 Lyons-Harrison Research Building, University of Alabama at Birmingham, Birmingham, Alabama 35294-0007, USA. E-mail: paul [email protected]

APPENDIX Abbreviations used in this paper are: GAPDH, glyceraldehyde-3phosphate dehydrogenase; Hi-C, animals maintained on 8.0% NaCl chow and given chlorothiazide; Hi-F, animals maintained on 8.0% NaCl chow and given furosemide; Hi-salt, animals maintained on 8.0% NaCl chow; Lo-salt, animals maintained on 0.3% NaCl chow; Mid-salt, animals maintained on 1.0% NaCl chow; TALH, thick ascending limb of the loop of Henle; THP, Tamm-Horsfall glycoprotein.

REFERENCES 1. TAMM I, HORSFALL FL JR: Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med 74:108 –114, 1950

1155

2. MUCHMORE AV, DECKER JM: Uromodulin: A unique 85 kD immunosuppressive glycoprotein isolated from urine of pregnant women. Science (Wash) 229:479 – 481, 1985 3. PENNICA D, KOHR WJ, KUANG W-J, GLAISTER D, AGGARWAL BB, CHEN EY, GOEDDEL DV: Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein. Science (Wash DC) 236:83– 88, 1987 4. HESSION C, DECKER JM, SHERBLOM AP, KUMAR S, YUE CC, MATTALIANO RJ, TIZARD R, KAWASHIMA E, SCHMEISSNER U, HELETKY S, CHOW EP, BURNE CA, SHAW A, MUCHMORE AV: Uromodulin (Tamm-Horsfall glycoprotein): A renal ligand for lymphokines. Science (Wash) 237:1479 –1484, 1987 5. BACHMANN S, METZGER R, BUNNEMANN B: Tamm-Horsfall proteinmRNA synthesis is localized to the thick ascending limb of Henle’s loop in rat kidney. Histochemistry 94:517–523, 1990 6. BONDY C, CHIN E, SMITH BL, PRESTON GM, AGRE P: Developmental gene expression and tissue distribution of the CHIP28 water-channel protein. Proc Natl Acad Sci USA 90:4500 – 4504, 1993 7. ECELBARGER CA, TERRIS J, FRINDT G, ECHEVARRIA M, MARPLES D, NIELSEN S, KNEPPER MA: Aquaporin-3 water channel localization and regulation in the rat kidney. Am J Physiol 269(Renal Fluid Electrolyte Physiol 38):F663–F672, 1995 8. MAUNSBACH AB, MARPLES D, CHIN E, NING G, BONDY CA, AGRE P, NIELSEN S: Aquaporin-1 water channel expression in human kidney. J Am Soc Nephrol 8:1–14, 1997 9. BACHMANN S, DAWNAY ABSJ, BOUBY N, BANKIR L: Tamm-Horsfall protein excretion during chronic alterations in urinary concentration and protein intake in the rat. Renal Physiol Biochem 14:236 –245, 1991 10. HUANG Z-Q, KIRK KA, CONNELLY KG, SANDERS PW: Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation. J Clin Invest 92: 2975–2983, 1993 11. HUANG Z-Q, SANDERS PW: Biochemical interaction of Tamm-Horsfall glycoprotein with Ig light chains. Lab Invest 73:810 – 817, 1995 12. SANDERS PW, HERRERA GA, CHEN A, BOOKER BB, GALLA JH: Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo. J Clin Invest 82:2086 –2096, 1988 13. SANDERS PW, BOOKER BB, BISHOP JB, CHEUNG HC: Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest 85:570 –576, 1990 14. SANDERS PW, BOOKER BB: Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 89:630 – 639, 1992 15. START DA, SILVA FG, DAVIS LD, D’AGATI V, PIRANI CL: Myeloma cast nephropathy: Immunohistochemical and lectin studies. Modern Pathol 1:336 –347, 1988 16. HESS B, ZIPPERLE L, JAEGER P: Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation. Am J Physiol 265(Renal Fluid Electrolyte Physiol 34): F784 –F791, 1993 17. CHEN PY, SANDERS PW: L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88:1559 –1567, 1991 18. ECELBARGER CA, TERRIS J, HOYER JR, NIELSEN S, WADE JB, KNEPPER MA: Localization and regulation of the rat renal Na1-K12Cl2 cotransporter, BSC-1. Am J Physiol 271(Renal Fluid Electrolyte Physiol 40):F619 –F628, 1996 19. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156 –159, 1987 20. FUKUOKA S-I, FREEDMAN SD, YU H, SUKHATME VP, SCHEELE GA: GP-2/THP gene family encodes self-binding glycosylphosphatidylinositol-anchored proteins in apical secretory compartments of pancreas and kidney. Proc Natl Acad Sci USA 89:1189 –1193, 1992 21. BACHMANN S, KOEPPEN-HAGEMANN I, KRIZ W: Ultrastructural localization of Tamm-Horsfall glycoprotein (THP) in rat kidney as revealed by protein A-gold immunocytochemistry. Histochemistry 83: 531–538, 1985 22. RINDLER MJ, NAIK SS, LI N, HOOPS TC, PERALDI M-N: Uromodulin (Tamm-Horsfall glycoprotein/uromucoid) is a phosphatidylinositollinked membrane protein. J Biol Chem 265:20784 –20789, 1990

1156

Ying and Sanders: Dietary salt controls production of THP

23. GALLA JH, BOOKER BB, LUKE RG: Dietary NaCl intake alters chloride reabsorption in the loop segment of superficial nephrons. Presented at the American Society of Nephrology. Washington D.C., 1986 24. MCQUEEN EG, ENGEL GB: Factors determining the aggregation of urinary mucoprotein. J Clin Pathol (Lond) 19:392–396, 1966 25. STEVENSON FK, CLEAVE AJ, KENT PW: The effect of ions on the viscometric and ultracentrifugal behaviour of Tamm-Horsfall glycoprotein. Biochim Biophys Acta 236:59 – 66, 1971 26. WIGGINS RC: Uromucoid (Tamm-Horsfall glycoprotein) forms different polymeric arrangements on a filter surface under different physicochemical conditions. Clin Chim Acta 162:329 –340, 1987 27. WIRDNAM PK, MILNE RDG: Tamm-Horsfall glycoprotein release from rat kidney cortex slices in vitro. Clin Sci 67:529 –534, 1984

28. GRANT AMS, NEUBERGER A: The development of a radioimmunoassay for the measurement of urinary Tamm-Horsfall glycoprotein in the presence of sodium dodecyl sulphate. Clin Sci 44:163–179, 1973 29. HESS B, NAKAGAWA Y, COE FL: Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257(Renal Fluid Electrolyte Physiol 26):F99 –F106, 1989 30. HESS B, NAKAGAWA Y, COE FL: Molecular abnormality of TammHorsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 260(Renal Fluid Electrolyte Physiol 29):F569 –F578, 1991 31. CIRILLO M, LAURENZI M, PANARELLI W, STAMLER J: Urinary sodium to potassium ratio and urinary stone disease. Kidney Int 46:1133–1139, 1994 32. STAMLER J, CIRILLO M: Dietary salt and renal stone disease. Lancet 349:506 –507, 1997